ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

Support Contracts For Management Info, ODQ Updating Ok’d

October 12, 1990

ZBB Considered Useless By NCI Staff (Privately)’ New Approach Groups Program Into Four Categories

October 6, 1978

NIEHS Awards $5M Grant for New Health Sciences Center to Robert Wood Johnson Medical School

January 20, 1989

LeMaistre Blasts “Death Merchants’ In tobacco Industry

May 5, 1989

ASCO honors physicians for clinical trials participation.

June 4, 2004

Schmitt To Chair Senate Health Appropriations Subcommittee

January 2, 1981